New Activities
ON-DEMAND Beyond the pill: ...
This joint webinar was hosted by the AMR Declaration Trust and the Alliance for the Prudent Use of Antibiotics (APUA) ...
Watch webinarZero by 2023: One Health perspectives ...
Organised by the ISAC Viral Infections Working GroupThis webinar aims to raise awareness of various aspects related to rabies for ...
RegisterJust published - ISAC / APUA Newsletter
Download the latest ISAC / APUA Newsletter which contains features articles, a round-up of the latest AMR news as well as ...
Read nowThe Antibiogram Training Project
ISAC is delighted to share this free training project to assist laboratories in developing and sharing hospital antibiograms.
DownloadMembrane lipid remodelling confers ...
The on-demand recording of the latest ISAC Early Career Working Group webinar is now available.
Watch webinarISAC Project Grants
There is only one month to apply for an ISAC Project Grant. Applications invited from ISAC Member Societies for between &...
Apply nowAntibiotic allergy - a risk worth ...
In this lecture, Dr Trubiano presents on setting up an antibiotic allergy programme:
Watch nowAntibiotic summary cards
The Alliance for the Prudent Use of Antibiotics (APUA) and the International Society of Antimicrobial Chemotherapy (ISAC) are proud to ...
View/DownloadFever in returning travellers ISAC ...
ISAC is pleased to announce the launch of a second free E-module which has been developed as part of a ...
More info
32nd ICC on-demand
We are pleased to share the plenary and keynote lectures from the 32nd International Congress of Antimicrobial Chemotherapy (ICC) which was held in Perth, Australia in November 2022.
Sign up to ISAC's YouTube Channel to be the first to watch more excellent plenary and keynote lectures from the 32nd ICC which are posted weekly.
ICC lectures

Antibiotic allergy - a risk worth taking?
A/Prof. Jason Trubiano
Associate Prof. Jason Trubiano is the Director of the Department of Infectious Diseases, Austin Health and Head of the Drug and Antibiotic Allergy Service.
In this lecture, Dr Trubiano aims to address the following questions in relation to setting up an antibiotic allergy programme:
1. WHY should I address antibiotic allergy?
2. WHAT model of care should I employ for my setting?
3. HOW do I delabel / how do I do it?
4. WHAT should I prescribe?

Current management of Staphylococcus aureus
Prof. Steven Tong
In this lecture on management of S. aureus, Prof. Steven Tong (Doherty Institute, Royal Melbourne Hospital), presents on the following topics:
* Epidemiology
* Principles of care
* Current controversies
- Echocardiography
- Penicillin susceptible S. aureus (PSSA)
- Methicillin sensitive S. Aureus (MSSA)
- Oral switch
- PET/CT scans

Plenary 5: AMR control under One Health
Prof. Ramanan Laxminarayan
Global leader Prof. Ramanan Laxminarayan presents an excellent plenary lecture on understanding how antimicrobial resistance (AMR) should be managed in the One Health context.
Topics covered include:
* Drug resistance overview
* One Health concept
* Antimicrobials in food producing animals
* Antimicrobials in aquaculture
* Climate change and antibiotic resistance
* Global warming and fungal pathogens
* Interacting with the environment
* Using One Health framework to prevent resistance
* Surveillance networks
* Q&A with Prof. John Turnidge

Keynote 1: New therapeutic developments for fungal infections
Prof. Monica Slavin
In the lecture, Dr Slavin discusses the following:
1. Need for new antifungals
2. New treatment options in clinical trials: focus on rezafungin, brexafungerp, manogepix and olorofim
3. Update on azoles
4. Other advances
5. Conclusion and future directions

Plenary 4: HIV to COVID-19 & beyond: the role of antivirals in responding to pandemics
Prof. Sharon Lewin
Topics include direct acting antivirals for COVID-19, the delay in antiviral development for COVID-19, molecular technology platforms for antiviral development and the challenge of implementation.

Plenary 3: Phages – from personalised therapy to regulatory approval
Prof. Jon Iredell
Prof. Iredell presents strategies to develop novel phage therapy from regulatory approval to personalised therapy.

Plenary 2: Treatment of multidrug resistant Pseudomonas aeruginosa infections
Prof. Juan-Pablo Horcajada
Topics discussed include:
* Importance and frequency of MDR Pseudomonas aeruginosa infections
* High-risk clones. Mechanisms of resistance
* Treatment with colistin
* Hollow fiber model applied to P. aeruginosa infections
* Current antimicrobial options

Plenary 1: Microbial Theranostics - a Resistance Combatting Strategy
Prof. Robin Patel
In this lecture, Prof. Patel presents a potential strategy to help in the fight against the global antimicrobial resistance crisis through better diagnostics and better use of diagnostics.
Prof. Patel was awarded the Hamao Umezawa Memorial Award (HUMA) which is the highest award given by ISAC for outstanding contributions in the field of antimicrobial chemotherapy. The award is generously sponsored by the Microbial Chemistry Research Foundation of Japan.